Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Does low immunoglobulin A increase risk of gut infections and inflammation?

IgA is the primary mucosal antibody in the gut and low IgA increases susceptibility to gastrointestinal infections and dysbiosis-driven inflammation.

SupportedJune 19, 202623 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Immunoglobulin A is a key mucosal antibody that helps contain microbes at the gut surface, and low immunoglobulin A is associated with higher susceptibility to gastrointestinal infections and dysbiosis-driven inflammation.

laying out figure…
All 12 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that secretory IgA acts as the main immunological barrier at the intestinal surface by excluding and agglutinating microbes and by selectively coating commensals to maintain microbial balance. When IgA is low or absent this containment fails, allowing pathogen colonization, loss of microbial diversity, and Th17-driven mucosal inflammation that promotes chronic gut disease.

Verified conclusion

Immunoglobulin A (IgA) is the primary immunological barrier of the gastrointestinal tract, and its presence is essential for maintaining a healthy balance between the host and the trillion of microbes residing in the gut. Evidence confirms that IgA is the most abundant antibody at mucosal surfaces, where it serves as a critical guardian of the intestinal lining.

Clinical and effectiveness evidence

Low levels of IgA, particularly in the context of Selective IgA Deficiency (SIgAD), are strongly associated with increased clinical vulnerability.

  • Infection Risk: Individuals with low IgA exhibit a significantly higher frequency of gastrointestinal infections. In pediatric cohorts with SIgAD, combined respiratory and GI infection rates have been recorded as high as 98%.
  • Pathogen Susceptibility: The absence of IgA specifically facilitates colonization by opportunistic pathogens such as Giardia lamblia, which are typically excluded by a robust mucosal immune response.
  • Inflammatory Link: Beyond infection, low IgA levels are linked to a higher prevalence of inflammatory bowel disease (IBD) and celiac disease, highlighting its role in preventing the transition from a healthy gut to a chronically inflamed state.

Mechanistic explanations

The protective capacity of IgA is driven by several sophisticated biophysical and immunological pathways:

  • Immune Exclusion: IgA prevents pathogens from attaching to the gut wall through a process called "immune exclusion." It binds to microbial antigens, creating immune complexes that are physically swept away by mucus and peristalsis.
  • Agglutination: IgA can "clump" bacteria together (agglutination), effectively immobilizing them and preventing them from reaching the sensitive epithelial layer.
  • Microbial Regulation (The IgA-Biome): IgA actively shapes the microbiome by coating beneficial bacteria to promote their colonization while targeting proinflammatory "pathobionts." In its absence, there is a marked decrease in diversity (e.g., loss of Bacteroidetes) and an overgrowth of Proteobacteria.
  • Th17 Activation: When IgA is deficient, the resulting dysbiosis triggers a persistent activation of Th17 immune cells. This leads to an overproduction of proinflammatory cytokines like IL-17, TNF-α, and IL-1β, which drive mucosal damage.

Bottom line

The evidence strongly supports the claim: IgA is indispensable for containing gut microbes and preventing dysbiosis. Low IgA levels directly increase the risk of gastrointestinal infections and fuel a cycle of inflammation by allowing proinflammatory bacteria to proliferate and compromise the intestinal barrier.

References

  1. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut — pmc.ncbi.nlm.nih.gov ↗
  2. Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces — pmc.ncbi.nlm.nih.gov ↗
  3. Flagellar-based motility accelerates IgA-mediated agglutination of Salmonella Typhimurium at high bacterial cell densities — frontiersin.org ↗
  4. Secretory IgA in Intestinal Mucosal Secretions as an Adaptive Barrier against Microbial Cells — pmc.ncbi.nlm.nih.gov ↗
  5. Descriptive review of clinical data from 186 records of outpatients with IgA deficiency accompanied at a quaternary hospital in Brazil — pmc.ncbi.nlm.nih.gov ↗
  6. Clinical manifestation for immunoglobulin A deficiency: a systematic review and meta-analysis — pmc.ncbi.nlm.nih.gov ↗
  7. Understanding the natural history of selective IgA deficiency — linkinghub.elsevier.com ↗
  8. [Selective IgA deficiency]. — linkinghub.elsevier.com ↗
  9. Incidence, Management Experience and Characteristics of Patients with Giardiasis and Common Variable Immunodeficiency — mdpi.com ↗
  10. Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation — pmc.ncbi.nlm.nih.gov ↗
  11. IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM — pmc.ncbi.nlm.nih.gov ↗
  12. Secretory IgA in breast milk protects against asthma through modulation of the gut microbiota. — linkinghub.elsevier.com ↗
  13. Gut dysbiosis, low-grade inflammation, and renal impairment severity in elderly diabetic nephropathy — wjgnet.com ↗
  14. Selective IgA deficiency in humans is associated with reduced gut microbial diversity. — linkinghub.elsevier.com ↗
  15. Secretory IgA dysfunction underlies poor prognosis in Fusobacterium-infected colorectal cancer — tandfonline.com ↗
  16. Mitochondrial dysfunction promotes microbial composition that negatively impacts on ulcerative colitis development and progression — pmc.ncbi.nlm.nih.gov ↗
  17. The Underappreciated Role of Secretory IgA in IBD. — pmc.ncbi.nlm.nih.gov ↗
  18. IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulation — pmc.ncbi.nlm.nih.gov ↗
  19. Relationship between selective IgA deficiency and COVID-19 prognosis. — jstage.jst.go.jp ↗
  20. Immunoglobulin A–specific deficiency induces spontaneous inflammation specifically in the ileum — pmc.ncbi.nlm.nih.gov ↗
  21. Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression — pmc.ncbi.nlm.nih.gov ↗
  22. Growing, evolving and sticking in a flowing environment: understanding IgA interactions with bacteria in the gut — pmc.ncbi.nlm.nih.gov ↗
  23. Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes low-normal vitamin D weaken immune resilience?→Plausible11 sourcesCan low zinc and low vitamin D constrain immune pathways while an optimal hs-CRP does not support active systemic inflammation?→